C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2112425
Abstract of the Disclosure The new pyridopyrimidine derivative of the formula (A), wherein n denotes an integer of 0 to 3, Q stands for -(CH2) n - ( m denotes an integer of 0 to 2), -O-, -S(O)p - ( p denotes an integer of 0 to 2 ) or -N-, and R1 to R5 stand for substituents, or its salt is described. Preparation of them and use to endothelin receptor antagonistic agent are exemplified. An endothelin receptor antagonist consisting of said compound is effective as therapeutic composition of acute renal insufficiency, myocardial infraction, hypertension, cerebral infarction, angina pectoris, arteriosclerosis, hepatopathy, pulmonary hypertension, bronchial asthma, organohypofunction occuring during operation or transplantation of organs. Image (A)
Furuya Shuichi
Ohtaki Tetsuya
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
LandOfFree
Pyridopyrimidine derivatives, their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridopyrimidine derivatives, their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrimidine derivatives, their production and use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1464146